Esophageal Cancer
Siewert type II adenocarcinomas distinguished from type III
Published in Cancer Weekly, April 24th, 2006
According to recent research from Japan, "Since Misumi et al. and Siewert proposed a new classification for carcinoma of the gastroesophageal junction (GEJ), few surgical studies using these criteria have been reported from Eastern countries. Siewert type II adenocarcinomas are managed using general rules for either gastric or esophageal cancer. We set out to determine whether type II adenocarcinoma is a distinct clinical entity requiring a more specific treatment plan."
"Among 125 Japanese patients who underwent resection of adenocarcinoma of the GEJ (type I, 2; type II, 44; type III,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-04-24)
More Articles from Cancer Weekly
- Astrocytomas
Gliomas graded using metabolite quantification with MR spectroscopic imaging - Colorectal Cancer
Colorectal cancer prognosis linked to indoleamine 2,3-dioxygenase expression - Lung Cancer
Lung cancer apoptosis enhanced by adenylate cyclase toxin - Ovarian Cancer
Ovarian cancer risk not linked to dietary fat, cholesterol and egg intakes - Prostate Cancer
Prostate cancer quality of life affected by spirituality - Abdominal Cancer
Habitual inclusion of pelvis on abdominal CT for abdominal tumors not justified - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
